-
Amicus Therapeutics Prices Underwritten Offering of Common Stock
-
Amicus Therapeutics Prices Underwritten Offering of Common Stock
-
Amicus Therapeutics (FOLD) Announces $150M Common Stock Offering
-
Amicus Therapeutics Announces Public Offering of Common Stock
-
Amicus Therapeutics Announces Public Offering of Common Stock
-
Amicus Therapeutics (FOLD) Closes 13.85M Common Offering
-
Amicus Therapeutics Announces Closing of Underwritten Offering of Common Stock and Full Exercise of Over-Allotment Option
-
Amicus Therapeutics (FOLD) Prices 13.85M Common Secondary at $6.50/Share
-
Amicus Therapeutics (FOLD) Reports $75M Stock Offering
-
Notable Analyst Rating Changes 07/01: (NFLX) (FOLD) (NBR) Upgraded; (GS) (MNKD) (URBN) Downgraded
-
Janney Upgrades Amicus Therapeutics (FOLD) to Buy
-
Janney Downgrades Amicus Therapeutics (FOLD) to Neutral
-
Unusual 11 Mid-Day Movers 01/03: (SPWR) (LDK) (BGMD) Higher; (LPH) (ALLT) (MLNX) Lower
-
Janney Montgomery Scott Starts Amicus Therapeutics (FOLD) at Buy